Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.
Saved in:
| Title: | Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3. |
|---|---|
| Authors: | Bressler NM; Wilmer Photograph Reading Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21205-2002, USA. nmboffice@jhmi.edu, Arnold J, Benchaboune M, Blumenkranz MS, Fish GE, Gragoudas ES, Lewis H, Schmidt-Erfurth U, Slakter JS, Bressler SB, Manos K, Hao Y, Hayes L, Koester J, Reaves A, Strong HA |
| Corporate Authors: | Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group |
| Source: | Archives of ophthalmology (Chicago, Ill. : 1960) [Arch Ophthalmol] 2002 Nov; Vol. 120 (11), pp. 1443-54. |
| Publication Type: | Clinical Trial; Comparative Study; Journal Article; Meta-Analysis; Randomized Controlled Trial |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 7706534 Publication Model: Print Cited Medium: Print ISSN: 0003-9950 (Print) Linking ISSN: 00039950 NLM ISO Abbreviation: Arch Ophthalmol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
